Pharmacology · Glossary
Ligand
Also written: receptor ligand · endogenous ligand · natural ligand
Definition
A ligand is a molecule that binds a biological target such as a receptor; binding alone does not say whether it activates or blocks the target.
What is a ligand? A ligand is any molecule that binds to a receptor or another biological target. Binding is the whole membership test: an agonist binds and activates, while an antagonist binds without activating. Every agonist is a ligand, but not every ligand is an agonist.
How do ligand, agonist, and antagonist fit together?
Ligand is the umbrella term; agonist and antagonist describe what certain ligands do after binding. An agonist activates its receptor. An antagonist blocks activation by another ligand. The ligand vs receptor distinction is the relationship: the ligand binds, and the receptor receives.
Think of the receptor as a lock. A ligand is any key-shaped object that fits. An agonist turns the lock; an antagonist prevents the working key from getting in. The IUPHAR nomenclature keeps binding site and biological effect as separate questions.
What is a natural ligand?
A natural ligand, also called an endogenous ligand, is made by the body and binds its biological target. Ghrelin is one clean peptide example: researchers identified the 28-amino-acid hormone as the endogenous ligand for the growth-hormone secretagogue receptor (Kojima et al., 1999).
A drug can be built to imitate that natural message. Synthetic ghrelin-receptor agonists bind the same receptor and switch it on. That is the useful ligand definition pharmacology gives a drug reader: “ligand” says what binds; “agonist” or “antagonist” says what the binding does.
Why does ligand meaning matter in peptide research?
Ligand meaning matters because binding is not the same as benefit. For ligand meaning, biology starts with the binding relationship, not the result. A cell assay can show binding, but that is mechanistic evidence, not proof of a human outcome. Animal results and human trials remain separate evidence tiers.
Ligands also bind proteins that are not receptors. Follistatin, for example, acts as a “ligand trap,” catching signals before they reach receptors. A follistatin-based construct neutralized myostatin, activins, and GDF-11 in laboratory assays, then produced local muscle effects in mice (Pearsall et al., 2019). That result is preclinical, not human efficacy evidence.
What should you check when a paper says ligand?
Start by asking what the ligand binds, then what happened after binding. The answer to what is a ligand does not settle binding affinity, agonist or antagonist behavior, or evidence tier. “Ligand” is a relationship label, not a verdict on potency, safety, approval, or whether a product works in people.